N/A
Completed N=153
Product Evaluation of a Newly Developed Intermittent Catheter.
Incontinence, Urinary
Source: ClinicalTrials.gov NCT02966015 ↗
Enrolled (actual)
153
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcomePrimary: Number of Participants Successfully Able to Insert Catheter — 82; 58 Participants
Summary
The aim of the study is to investigate the navigation of a newly developed catheter.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Successfully Able to Insert Catheter |
82; 58 | — |
Eligibility Criteria
Inclusion Criteria
- Male and at least 18 years
- Has used Intermittent self-catheterization at least 3 months
- Has normal to slightly reduced hand mobility
- Use catheter size CH12 or CH14 (must use same size during product evaluation)
Exclusion Criteria
- Currently receiving treatment for urinary tract infection
- Currently receiving chemotherapy
Data sourced from ClinicalTrials.gov (NCT02966015). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.